Novanta Inc. (NOVT): Price and Financial Metrics


Novanta Inc. (NOVT)

Today's Latest Price: $102.95 USD

1.83 (1.81%)

Updated Sep 25 4:00pm

Add NOVT to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 138 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

NOVT Stock Summary

  • With a price/earnings ratio of 85.15, Novanta Inc P/E ratio is greater than that of about 91.26% of stocks in our set with positive earnings.
  • The price/operating cash flow metric for Novanta Inc is higher than 91.31% of stocks in our set with a positive cash flow.
  • The volatility of Novanta Inc's share price is greater than that of merely 13.83% US stocks with at least 200 days of trading history.
  • Stocks that are quantitatively similar to NOVT, based on their financial statements, market capitalization, and price volatility, are PRGS, MKSI, DGII, FLIR, and CPSI.
  • Visit NOVT's SEC page to see the company's official filings. To visit the company's web site, go to www.novanta.com.
NOVT Daily Price Range
NOVT 52-Week Price Range

NOVT Stock Price Chart Technical Analysis Charts


NOVT Price/Volume Stats

Current price $102.95 52-week high $117.93
Prev. close $101.12 52-week low $66.44
Day low $100.85 Volume 70,324
Day high $103.44 Avg. volume 134,220
50-day MA $105.99 Dividend yield N/A
200-day MA $95.53 Market Cap 3.62B

Novanta Inc. (NOVT) Company Bio


Novanta Inc. designs, develops, manufactures, and sells precision photonic and motion control components, and subsystems to original equipment manufacturers in the medical equipment and advanced industrial technology markets. The company operates through three segments: Laser Products, Vision Technologies, and Precision Motion. The company was founded in 1968 and is based in Bedford, Massachusetts.

NOVT Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$102.95$35.48 -65%

The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Novanta Inc. To summarize, we found that Novanta Inc ranked in the 21th percentile in terms of potential gain offered. Our DCF analysis suggests the stock is overvalued by about 64.83%. In terms of the factors that were most noteworthy in this DCF analysis for NOVT, they are:

  • The company's debt burden, as measured by earnings divided by interest payments, is 6.76; that's higher than 62.67% of US stocks in the Technology sector that have positive free cash flow.
  • 93% of the company's capital comes from equity, which is greater than 83.28% of stocks in our cash flow based forecasting set.
  • The business' balance sheet reveals debt to be 7% of the company's capital (with equity being the remaining amount). Approximately merely 16.68% of US stocks with free cash flow have a lower reliance on debt in their capital structure.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%-66%
1%-65%
2%-65%
3%-65%
4%-64%
5%-64%

For other companies in the Technology that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as NOVT, try FICO, JKHY, PRCP, INTU, and VRSN.


NOVT Latest News Stream


Event/Time News Detail
Loading, please wait...

NOVT Latest Social Stream


Loading social stream, please wait...

View Full NOVT Social Stream

Latest NOVT News From Around the Web

Below are the latest news stories about Novanta Inc that investors may wish to consider to help them evaluate NOVT as an investment opportunity.

New MOVIA 2-Axis Scan Head Complements Laser Beam-Steering Portfolio

BEDFORD, Mass.--(BUSINESS WIRE)-- #CambridgeTechnology--New MOVIA 2-axis scan head from Cambridge Technology, a business unit of Novanta, is compatible with a majority of lasers for processing materials.

Business Wire | September 9, 2020

New Handheld Scanner Integrates LF/HF RFID and 1D/2D Barcode

SYRACUSE, N.Y.--(BUSINESS WIRE)-- #InnovationsThatMatter--JADAK, a business unit of Novanta, launches the HS-1RS Secure Access Handheld Barcode Scanner, enabled with software from Imprivata and HID.

Business Wire | August 26, 2020

Has Novanta (NASDAQ:NOVT) Got What It Takes To Become A Multi-Bagger?

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...

Yahoo | August 20, 2020

Novanta to Present at the Baird Global Healthcare Conference on Wednesday, September 9, 2020

Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matthijs Glastra, Chief Executive Officer, and Robert Buckley, Chief Financial Officer, are scheduled to present at the Baird Global Healthcare Conference on Wednesday, September 9, 2020, which is being held virtually.

Yahoo | August 14, 2020

Novanta, Inc. (NOVT) CEO Matthijs Glastra on Q2 2020 Results - Earnings Call Transcript

Novanta, Inc. (NOVT) Q2 2020 Earnings Conference Call August 06, 2020 10:00 AM ET Company Participants Ray Nash - Corporate Finance Leader Matthijs Glastra - Chief Executive Officer Robert Buckley - Chief Financial Officer Conference Call Participants Joe Jagoda - CJS Securities Rick Eastman - Robert W. Baird Brian Drab...

SA Transcripts on Seeking Alpha | August 9, 2020

Read More 'NOVT' Stories Here

NOVT Price Returns

1-mo -5.06%
3-mo 3.01%
6-mo 34.07%
1-year 25.86%
3-year 143.96%
5-year 736.31%
YTD 16.41%
2019 40.38%
2018 26.00%
2017 138.10%
2016 54.19%
2015 -7.47%

Continue Researching NOVT

Want to see what other sources are saying about Novanta Inc's financials and stock price? Try the links below:

Novanta Inc (NOVT) Stock Price | Nasdaq
Novanta Inc (NOVT) Stock Quote, History and News - Yahoo Finance
Novanta Inc (NOVT) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.86 seconds.